An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Clinical trial NCT02667587 · COMPLETED
Trial details
- NCT number
- NCT02667587
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2020-12-22
- Enrollment
- 716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.